BIOTECH STOCKS ARE POISED TO PAY OFF IN THE 1990s
Forget about price/earnings ratios. Forget about book value, hidden assets, or other traditional measures of value. Instead, think about potential, about sky's-the-limit growth. If that kind of inv...
View ArticlePRODUCTS TO WATCH
INTELLIGENT CAMERA How's this for a snapshot. About the only thing Minolta's new Freedom Zoom 105i camera doesn't do is click the shutter. A programmed circuit activated by a sensor automatically a...
View ArticleMEDICINE/ HEPATITIS C, THE QUIET EPIDEMIC
It's a blood-borne disease, transmitted through transfusions, sex, and shared needles. And it's a silent disease; people can go years before developing any symptoms.
View ArticleA Banana a Day...
Charles Arntzen, white-haired and engaging, has dropped in on the vaccine research project he brought to Cornell's Boyce Thompson Institute for Plant Research back in the mid-'90s. He runs from mee...
View ArticleThis Won't Hurt A Bit
Anthrax is today's big story. Tomorrow's could be smallpox--a highly contagious disease that's fatal 30% of the time. There's no treatment for smallpox. The good news, such as it is, is this: If a ...
View ArticleSurvey: Adults still skip condom use
Americans claim to be savvy about sexually transmitted diseases, but knowing a few facts is not keeping them from taking many risks, according to a national survey.
View ArticleHow to travel healthy
Getting organized for a trip overseas can be a stressful experience. There are passports, visas and tickets to arrange, accommodations to book, prescriptions to fill and pet sitters to hire -- and, if...
View ArticleBristol-Myers feels bite of patent loss
Bristol-Myers Squibb, which reports earnings on Thursday, is feeling the familiar sting of patent loss, though analysts said the company's robust pipeline could make it a promising long-term investment.
View ArticleVertex stock soars on upgrade
The stock price for Vertex Pharmaceuticals surged following an upgrade from J.P. Morgan on Friday, as the small drug maker moves ahead with testing on an experimental treatment for hepatitis C.
View ArticleBiotech stocks in the dog house
It wasn't that long ago that fast-rising biotech stocks were selling for boutique prices. Well, those days are done, and biotech's slumping performance this year has put them within reach of the...
View ArticleHepatitis drug from Vertex could reap billions
Vertex Pharmaceuticals, a small biotech, and its marketing partner Johnson & Johnson stand to gain billions of dollars in annual sales if their experimental hepatitis drug is successful, analysts say.
View ArticleBristol-Myers earnings tumble 64 percent
Bristol-Myers Squibb Co. on Thursday said third-quarter earnings fell as sales of its anti-clotting drug Plavix and other drugs were hurt by competition from cheaper generics.
View ArticleBristol-Myers not for sale: interim CEO
Bristol-Myers Squibb is looking for a new chief executive, not a buyer, according to the company's interim CEO.
View ArticleStudy: Liver Cancer Breakthrough
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people...
View ArticleDoc suspected in hepatitis C cases; testing urged for 4,500
Letters are on the way to 4,500 patients of an anesthesiologist who is suspected of infecting three people with hepatitis C last August, the New York City Health Department says.
View ArticleLove your liver to live longer
The liver is a hardy organ but it's prone to abuse. Most people think their livers can cope with regular alcohol consumption, fatty food and a sedentary lifestyle, but liver disease is on the rise in...
View ArticleSchering-Plough profits rise
Schering-Plough Corp. said Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
View ArticleJamba Juice warns customers of hepatitis risk
About 4,000 customers could be at risk after a worker at a Jamba Juice store in San Jose, California, developed hepatitis A, the chief medical officer for Santa Clara County said Thursday.
View ArticleA biotech pioneer takes on Big Pharma
The power went out at Hammersmith Hospital just a few minutes after I started chatting with Sunil Shaunak, a professor who specializes in drug discovery for infectious diseases.
View Article
